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In 1959 Richard Feynman’s seminal talk on
nanotechnology, “There’s Plenty of Room at
the Bottom,” presented what was theoretically
possible by manipulating matter at the atomic
and molecular scales. Today, nanotechnology
is an applied science, a rapidly growing indus-
try generating a diverse array of nanoscale
materials and processes (e.g., carbon nano-
tubes, fullerene derivatives, quantum dots).
Manipulation of materials and processes on a
nanometer scale is opening a world of creative
possibilities, and the benefits afforded by
nanoscale technologies are expected to have
substantial impacts on almost all industries and
areas of society (e.g., medicine, plastics, energy,
electronics, aerospace). It is such creative
potential that renders nanotechnology of sig-
nificant social and economic value. With
approximately $8.6 billion invested in nano-
technology research and development world-
wide in 2004 (Nordan et al. 2004), and a
projected nanotechnology economy valued at
$1 trillion by 2012 (Service 2004), the preva-
lence of these materials in society is ensured,
and human exposures, as well as those of
wildlife, are likely to increase. Currently, nan-
otechnology products are sold by more than
200 companies globally; some are widely used
in commercially available products (e.g., elec-
tronic, cosmetic) (Hood 2004; National
Science Foundation 2004). For perspective on
the size of nanoscale products, consider that
2 g of 100 nm-diameter nanoparticles contains
enough material to provide every human
worldwide with 300,000 particles each.
The nascent nature of the nanotechnology
industry, however, leaves many areas unexplored,
or underexplored, such as the potential adverse
effects of engineered nanomaterials on human
health and the environment. Currently, the
paucity of toxicologic information and lack of
standardized testing protocols make assessment
of the adverse effects of engineered nanosized
materials on biologic systems difﬁcult (National
Toxicology Program 2005; U.S. Environmental
Protection Agency 2003). The growing preva-
lence of nanomaterials in society, in conjunction
with their unique physicochemical properties
and the risk of unwanted/unanticipated expo-
sures, renders them of potential concern to
human health and the environment. It is within
this context that the need for understanding the
potentially harmful side effects of these materials
is becoming clear (Colvin 2003; Oberdörster
et al. 2005).
Reviewed here are novel nanomaterials
commonly referred to as quantum dots (QDs).
Although they offer potentially invaluable soci-
etal beneﬁts such as drug targeting and in vivo
biomedical imaging (Alivisatos 2004; Gao
et al. 2004; Michalet et al. 2005; Roco 2003),
they may also, as the reviewed literature sug-
gests, pose risks to human health and the envi-
ronment under certain conditions. Current
literature reveals that assessing QD exposure
routes and potential toxicity is not a simple
matter; not all QDs are alike, and toxicity
depends on multiple physicochemical as well
as environmental factors.
Applications of Quantum Dots
Quantum dots are semiconductor nanocrystals
(~ 2–100 nm) with unique optical and electri-
cal properties (Bruchez et al. 1998; Dabbousi
et al. 1997) currently applied in biomedical
imaging and electronics industries. One of the
more valuable properties of QDs is their ﬂuo-
rescence spectrum, which renders them opti-
mal fluorophores for biomedical imaging
(Alivisatos 2004; Chan et al. 2002). For
instance, ﬂuorescent QDs can be conjugated
with bioactive moieties (e.g., antibodies, recep-
tor ligands) to target specific biologic events
and cellular structures, such as labeling neo-
plastic cells (Gao et al. 2004; Wu et al. 2003),
peroxisomes (Colton et al. 2004), DNA
(Dubertret et al. 2002), and cell membrane
receptors (Beaurepaire et al. 2004; Lidke et al.
2004). Bioconjugated QDs are also being
explored as tools for site-speciﬁc gene and drug
delivery (Rudge et al. 2000; Scherer et al.
2001; Yu and Chow 2005) and are among the
most promising candidates for a variety of
information and visual technologies; they are
currently used for the creation of advance ﬂat-
panel LED (light-emitting diode) displays and
may be employed for ultrahigh-density data
storage and quantum information processing
(Wu et al. 2004).
Quantum Dot Physicochemical
Properties
Understanding the potential toxicity of QDs
requires a fundamental grasp of QD physico-
chemical properties. Although naturally occur-
ring biogenic and anthropogenic nanosized
particles abound in nature, engineered QDs
differ because of unique physicochemical prop-
erties that result from a combination of their
crystalline metalloid core structure/composition
and quantum-size conﬁnement, which occurs
when metal and semiconductor particles (QD
cores) are smaller than their Bohr radii
(~ 1–5 nm). Structurally, QDs consist of a
metalloid crystalline core and a “cap” or “shell”
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available via http://dx.doi.org/ [Online 20 September 2005]that shields the core and renders the QD
bioavailable (Figure 1). QD cores consist of a
variety of metal complexes such as semi-
conductors, noble metals, and magnetic tran-
sition metals. For instance, group III–V series
QDs are composed of indium phosphate
(InP), indium arsenate (InAs), gallium arsen-
ate (GaAs) and gallium nitride (GaN) metal-
loid cores, and group II–IV series QDs, of
zinc sulfide (ZnS), zinc–selenium (ZnSe),
cadmium–selenium (CdSe), and cadmium–
tellurium (CdTe) cores (Dabbousi et al. 1997;
Hines and Guyot-Sionnest 1996). Synthetic
routes to newer heavier structures (e.g., CdTe/
CdSe, CdSe/ZnTe) and hybrids composed of
lead–selenium (PbSe) have also been established
(Kim et al. 2003).
Further assignation of biocompatible coat-
ings or functional groups to the QD core–shell
can give QDs a desired bioactivity. Newly syn-
thesized QDs are inherently hydrophobic in
nature and not biologically useful, given a
hydrophobic cap formed on the metalloid core
during their synthesis in organic solvents. To
render them biologically compatible/active,
newly synthesized QDs are “functionalized,” or
given secondary coatings, which improves water
solubility, QD core durability, and suspension
characteristics and assigns a desired bioactivity.
For example, QD cores can be coated with
hydrophilic polyethylene glycol (PEG) groups
to render QDs biocompatible and can be fur-
ther conjugated with bioactive moieties to tar-
get speciﬁc biologic events or cellular structural
features (described above). Hence, bonding
various molecular entities to the QD core func-
tionalizes QDs for speciﬁc diagnostic or thera-
peutic purposes. Functionalization may be
achieved via electrostatic interactions, adsorp-
tion, multivalent chelation, or covalent bond-
ing, important physicochemical features when
considering QD durability/stability and in vivo
reactivity. In the literature, QD physicochemi-
cal characteristics are typically referred to as
“core–shell-conjugate” or vice versa. CdSe/ZnS,
for example, would refer to a QD with a CdSe
core and ZnS shell, and a CdSe/ZnS QD con-
jugated with sheep serum albumin (SSA) would
be referred to as CdSe/ZnS–SSA. Controlling
the physicochemical properties during synthe-
sis, which can be done with high precision,
allows tailoring QDs for speciﬁc functions/uses.
Herein lies both their strength and weak-
ness: QDs can be given highly speciﬁc bioac-
tivities by tailoring their coatings, for example,
for diagnostic (e.g., molecular imaging) and
therapeutic (e.g., drug delivery) purposes.
Their potential weakness is in the very coating
that makes them valuable: Compromise of the
coating can reveal the metalloid core, which
may be toxic either as a composite core (e.g.,
CdTe) or upon dissolution of the QD core to
constituent metals (e.g., Cd). Degradation of
the QD coating may also result in reaction of
the QD in undesirable/unanticipated ways
in vivo. Further, some QD coating materials
have themselves been found to be cytotoxic,
such as mercaptoacetic acid (MAA; discussed
further below). From this, it can be seen that
QD physicochemical properties are fundamen-
tal to understanding QD toxicity; it is the sta-
bility of QD core-coating bioactive complexes
that may render QDs potentially harmful, and
because QDs have been found to degrade
under photolytic and oxidative conditions,
QD stability likely will ﬁgure signiﬁcantly in
commercialization of QD products.
Quantum Dot Toxicity
Discussion of QD toxicity can be somewhat
confusing because of the diversity QDs being
synthesized. To make a review of this topic sim-
pler, it should be made clear that not all QDs
are alike. Each individual type of QD possesses
its own unique physicochemical properties,
which in turn determines its potential toxicity
or lack thereof. In general, there are discrepan-
cies in the current literature regarding the toxic-
ity of QDs that can be attributed to several
factors: the lack of toxicology-based studies, the
variety of QD dosage/exposure concentrations
reported in the literature, and the widely vary-
ing physicochemical properties of individual
QDs. Studies speciﬁcally designed for toxico-
logic assessment (e.g., dose, duration, frequency
of exposure, mechanisms of action) are few.
Many of the studies from which QD toxicity
information is derived and that have been cited
in reference to QD toxicity were performed by
nanotechnology researchers rather than toxicol-
ogists or health scientists. Most of the current
studies reviewed here were designed to ask
questions concerning the physicochemical
properties of novel QD products such as ﬂuo-
rescence, detectability, stability, and cell label-
ing efﬁcacy, not QD toxicity per se.
Importantly, and a potential source of con-
fusion in assessing QD toxicity, QD toxicity
depends on multiple factors derived from both
individual QD physicochemical properties and
environmental conditions: QD size, charge,
concentration, outer coating bioactivity (cap-
ping material, functional groups), and oxida-
tive, photolytic, and mechanical stability have
each been shown to be determining factors in
QD toxicity. For example, some QDs have
been found to be cytotoxic only after oxidative
and/or photolytic degradation of their core
coatings. Last, because QD dosage/exposure
concentrations reported in the literature vary in
their units of measurement (e.g., milligrams per
milliliter, molarity, milligrams per kilogram
body weight, number of QDs per cell), corre-
lating dosage across current studies is challeng-
ing. Following is a review of in vitro and in vivo
studies that describe the characteristics of QDs
that may render them potentially toxic to verte-
brate systems.
Routes of exposure. Although the potential
adverse effects of nanomaterials on the envi-
ronment and human health have recently been
addressed by research initiatives organized
under the National Science Foundation and
the U.S. Environmental Protection Agency, no
factual information is currently available
regarding routes of QD exposure. QD stabil-
ity, aerosolization, half-lives, and how they par-
tition into environmental media are currently
poorly understood. However, consideration of
exposure routes may be extrapolated from what
is known regarding materials of similar size and
physicochemical properties.
Potential routes of QD exposure are envi-
ronmental, workplace, and therapeutic or diag-
nostic administration. Workplace exposures
(e.g., engineers, researchers, clinicians) may
result from inhalation, dermal contact, or inges-
tion. For inhalation routes, an extensive body of
toxicologic research exists on other nanoscale
particles (e.g., asbestos, ultraﬁne particles) that
may provide a foundation from which to
approach QD inhalation studies. QDs vary in
size, ranging from approximately 2.5 nm up to
100 nm, depending on coating thickness, and
vary in their sites of deposition in pulmonary
tissues once aerosolized. For instance, QDs
< 2.5 nm may reach the deep lung and interact
with the alveolar epithelium, whereas larger
aerosolized QDs deposit in bronchial spaces.
However, under what conditions QDs
aerosolize and whether they form aggregates in
ambient air are not known (a salient review on
nanomaterials and inhalation exposures is given
by Oberdorster et al. 2005). Inhalation expo-
sures may pose potential risks given that QDs
have been shown to be incorporated via endo-
cytosis by a variety of cell types and may reside
in cells for weeks to months. What risks expo-
sures via dermal absorption and accidental
ingestion may pose is currently unknown.
What will likely be a signiﬁcant concern as
a route of exposure, given the social and eco-
nomic value of therapeutic/diagnostic QD
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Figure 1. QDs consist of a metalloid core and a
cap/shell that shields the core and renders the QD
bioavailable. The further addition of biocompatible
coatings or functional groups can give the QD a
desired bioactivity.
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CdSeproducts, are exposures resulting from QD
administration to humans for medicinal pur-
poses. These types of exposures are at present
theoretical, as QD products are not currently
approved for therapeutic/diagnostic pur-
poses; however, the potential for undesired/
unanticipated effects resulting from medicinal/
diagnostic administration of these materials
likely will ﬁgure prominently in the develop-
ment of medically based QD products. Their
potential toxicity via administrative routes of
exposure is highly dependent on a suite of vari-
able and poorly understood factors: QD tox-
ico- and pharmacokinetics, toxico- and
pharmacodynamics, and in vivo stability. It
may be that once QD kinetics and dynamics
are characterized, the risks posed by these expo-
sures may be mitigated through quality control
mechanisms (e.g., consistency and reliability
in volume production), as they currently are
with pharmaceuticals.
Exposures through environmental media
(contamination) are a potential route of con-
cern primarily because of QD metalloid core
compositions, and to some extent because of
QD core coatings. Many QD core metals (e.g.,
Cd, Pb, Se) are known to be toxic to vertebrate
systems at relatively low concentrations (parts
per million); however, understanding the risks
posed by QDs in the environment will prove
complex, as toxicity varies widely with the
chemical state of the metals, and environmental
transformation/degradation and partitioning
will determine the level of the human health
hazard. Currently, nothing is known regarding
the stability of QDs in the environment, prod-
uct lifetimes, or how these materials partition
into environmental media. Introduction of
QDs into environmental media may occur via
waste streams from industries that synthesize or
use QDs and via clinical and research settings.
Consequently, disposal of QD materials and
the risks of leakage and spilling during manu-
facturing and transport are potential sources of
concern. Environmental exposures are a signiﬁ-
cant source for several reasons: a) the environ-
mental concentration of anthropogenic
substances increases in direct proportion to
their use in society, and QDs, given their wide
range of applications, may see substantial pro-
duction volumes; b) the half-lives of these
materials may be quite long (months to possi-
bly years); and c) environmental exposure will
depend on where these materials partition
(e.g., air, water, soil types). Because of the
diversity of physicochemical properties among
varied types of QDs, it is likely that elucidating
environmental partitioning will be difficult.
These are important considerations given that
degradation of these materials in environmen-
tal media, in the event they reach environmen-
tal compartments, will undoubtedly occur, and
their rates of decay are likely to be highly vari-
able, depending on both QD physicochemical
characteristics and the environmental media in
which they partition. As mentioned, certain
types of QDs have been shown to degrade
under photolytic and oxidation conditions
(discussed further below).
Although little information currently exists
regarding routes of QD exposure, all routes
described are of potential concern given QDs
have been shown to be incorporated into a
variety of cell types via endocytotic mecha-
nisms. Current research also suggests that there
may be a risk of bioaccumulation of these
materials (e.g., metals) in organs and tissues, as
QDs have been shown to reside in cells for
weeks to months and potentially may present
problems with body burdens. Common to all
routes of exposure is the issue of QD stability.
Virtually nothing is known about QD metabo-
lism in vertebrate organisms or their routes of
excretion. Although QDs have been shown to
degrade under photolytic and oxidative condi-
tions, degradation products have not been
identiﬁed/deﬁned in vivo except for the release
of component core metals such as Cd and Se.
Finally, in considering routes of exposure, it is
important to remember that not all QDs are
alike; each individual QD type possesses its
own unique physicochemical properties that
will dictate its likely route of exposure.
QD cytotoxicity. In vitro studies suggest
certain QD types may be cytotoxic. Lovric
et al. (2005) found that CdTe QDs coated
with mercaptopropionic acid (MPA) and cys-
teamine were cytotoxic to rat pheochromo-
cytoma cell (PC12) cultures at concentrations
of 10 µg/mL. Uncoated CdTe QDs were
cytotoxic at 1 µg/mL. Cell death was charac-
terized as chromatin condensation and mem-
brane blebbing, symptomatic of apoptosis.
Cytotoxicity was more pronounced with
smaller positively charged QDs (2.2 ± 0.1 nm)
than with larger equally charged QDs (5.2 ±
0.1 nm) at equal concentrations (cytotoxicity
determined by MTT [3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide] assay.
QD size was also observed to affect subcellular
distribution, with smaller cationic QDs local-
izing to the nuclear compartment and larger
cationic QDs localizing to the cytosol. The
mechanisms involved in cell death were not
known but were considered to be due to the
presence of free Cd (QD core degradation),
free radical formation, or interaction of QDs
with intracellular components leading to loss
of function. The effect of QD-induced reac-
tive oxygen species on cell death was assessed
with N-acetylcysteine (NAC; a known
inhibitor of Cd toxicity), bovine serum albu-
min (BSA), and Trolox (a water-soluble vita-
min E). Both NAC and BSA but not Trolox
signiﬁcantly reduced CdTe QD toxicity, sug-
gesting that QD-induced toxicity may be par-
tially induced by Cd. A similar study by
Hoshino et al. (2004a) found that treatment
with the QD capping material mercapto-
undecanoic acid (MUA) alone (without QD)
for 12 hr caused severe cytotoxicity in murine
T-cell lymphoma (EL-4) cells at 100 µg/mL.
Treatment with cysteamine alone proved
weakly genotoxic at 100 µg/mL (12 hr).
Hence, in the Hoshino et al. (2004a) study,
cytotoxicity was attributed to QD capping
material rather than the core metalloid com-
plex itself. It is, however, unlikely that the tox-
icity observed by Lovric et al. (2005) can be
solely attributed to the QD coatings (MPA
and cysteamine), as both size and charge and
the effects of NAC and BSA suggest other-
wise. Brieﬂy, CdTe QD–induced cytotoxicity
in the Lovric et al. study was shown to be
partly dependent on QD size and may be due
to QD coating, intracellular reactions of the
surface coatings, or intracellular degradation of
QDs to metalloid ions. QD-induced cytotoxi-
city was also observed by Shiohara et al.
(2004): MUA-coated CdSe/ZnS QDs were
observed to be cytotoxic to HeLa cells and pri-
mary human hepatocytes at concentrations of
100 µg/mL (MTT assay).
Several in vitro and in vivo studies have
been cited in the literature as demonstrating a
lack of evidence for QD-induced cytotoxicity
(Ballou et al. 2004; Dubertret et al. 2002;
Hoshino et al. 2004a; Jaiswal et al. 2003;
Larson et al. 2003; Voura et al. 2004).
However, a few of the above studies do sug-
gest that QDs can affect cell growth and via-
bility. QD micelles, CdSe/ZnS QDs in a
hydrophobic core of n-polyethyleneglycol
phosphatidylethanolamine (PEG–PE) and
phosphatydilcholine, resulted in cell abnor-
malities (viability, motility) when injected into
Xenopus blastomeres at concentrations of 5 ×
109 QDs/cell (~ 0.23 pmol/cell), whereas cells
injected with 2 × 109 QDs/cell exhibited a
normal phenotype and were said to be statisti-
cally similar to uninjected embryos (Dubertret
et al. 2002). Hence, QD cytotoxicity was dose
dependent. Hoshino et al. (2004a) also found
QD-induced cytotoxicity to be dose depen-
dent. EL-4 cells incubated (106 cells/well)
with concentrations of 0.1, 0.2, and
0.4 mg/mL of CdSe/ZnS–SSA QDs exhibited
a dose–response relationship (24 hr). Cell via-
bility decreased at QD concentrations above
0.1 mg/mL, and almost all cells incubated
with 0.4 mg/mL were nonviable beyond 6 hr.
Interestingly, approximately 10% of EL-4 cells
retained QDs after 10 days of culture. The
ﬂuorescence intensity (QDs) of cells gradually
decreased and was highly concentrated in
endosomes, suggesting intracellular degrada-
tion of QDs. Although cytotoxicity was
observed at 0.1 mg/mL in vitro, EL-4 cells
incubated in 0.1 mg/mL SSA-conjugated
QDs, and subsequently injected into nude
mice (iv), were not observed to be toxic
in vivo. In a subsequent study, Hoshino et al.
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WTK1 cells (comet assay). DNA damage was
noted at 2 hr of treatment with 2 µM
QD–COOH (carboxylic acid), but after 12 hr
QD-induced DNA damage was efficiently
repaired.
QD-induced cytotoxicity was not observed
in several in vivo and in vitro studies. In an
in vivo study employing mice, Ballou et al.
(2004) injected (iv) amphiphilic polyacrylic
acid polymer-coated QDs (amp-QDs), and
amp-QDs conjugated to PEG-amine groups
(mPEG–QDs), at QD concentrations of
20 pmol QD/g animal weight. Necropsy
showed no signs of necrosis at the sites of tissue
deposition, and injected mice were viable for
133 days until the time of necropsy. No obvi-
ous sign of QD breakdown in vivo was detected
by electron microscopy (in vivo QD stability
was presumed to be due to the amphiphilic
polymer coating). In another in vivo study,
Larson et al. (2003) observed no noticeable ill
effects in mice injected (iv) with 20 nM and
1 µM solutions of CdSe/ZnS QDs (“ill effects”
was not deﬁned). Voura et al. (2004), treating
B16F10 melanoma cells with dihydroxy-
lipoic acid (DHLA)–capped CdSe/ZnS QDs
(5 µL/mL), noted no detectable difference in
growth between QD-treated and untreated
cells. Similarly, HeLa and Dictyostelium dis-
coideum cells treated with 400–600 nM con-
centrations of CdSe/ZnS QDs capped with
DHLA were observed to remain stably labeled
for more than a week with no detectable effects
on cell morphology or physiology (Jaiswal et al.
2003). Hanaki et al. (2003), exposing Vero
cells to 0.24 mg/mL (2-hr exposure, cells
washed and reincubated) CdSe/ZnS QDs
capped with MUA and coated with SSA, found
no effect of QDs on cell viability (MTT assay).
Although it was noted that Vero cells without
MUA–QD granules dominated the population
during successive cell divisions, the authors
stated they could not eliminate the possibility
that MUA-capped QDs affect the cell viability
when MUA-capped QDs are distributed in
the cytosol, because they had not investigated
it. Last, Chen and Gerion (2004), using
CdSe/ZnS QDs conjugated with the viral
SV40 nuclear localization signal peptide,
observed no cytotoxicity in HeLa cells trans-
fected with the peptide-coated QDs. The
authors observed that QD concentrations of
100 pmol/106 cells (~ 100 nM QD concentra-
tion) had minimal impact on cell survival
(measured by colonigenic assay).
Photolysis and oxidation: QD stability.
Possibly the most important aspect of QD tox-
icity is their stability, both in vivo and during
synthesis and storage. Several studies suggest
QD cytotoxicity to be due to photolysis or oxi-
dation. Under oxidative and photolytic condi-
tions, QD core–shell coatings have been found
to be labile, degrading and thus exposing
potentially toxic “capping” material or intact
core metalloid complexes or resulting in disso-
lution of the core complex to QD core metal
components (e.g., Cd, Se). Primary rat hepato-
cytes exposed to 62.5 µg/mL MAA–CdSe
QDs exhibited cell death, attributed to photo
lysis and oxidation of the QD coating. The
hepatotoxicity of MAA–tri-n-octylphosphine
oxide (MAA–TOPO)-capped CdSe QDs was
found to be dependent on QD processing con-
ditions and QD dose (Derfus 2004). If
MAA–TOPO-capped CdSe QDs were
exposed to air 30 min before MAA coating, a
marked dose-dependent decrease in cell viabil-
ity was observed, from 98 to 21%, at
62.5 µg/mL. Likewise, MAA–TOPO-capped
CdSe QDs exposed to ultraviolet (UV) light
(15 mW/cm2) showed a dramatic dose-depen-
dent decrease in cell viability, with longer
exposure times increasing toxicity (1–8 hr:
91% decrease in cell viability). It was con-
cluded that prolonged exposure of QDs to
oxidative and photolytic environments can
cause decomposition of MAA–TOPO-capped
CdSe QD nanocrystals. Relatively high con-
centrations of free Cd were observed in the
medium of QD solutions exposed to air
(126 ppm) and UV (82 ppm), with 6 ppm
nonoxidized QD core material (CdSe) remain-
ing in solution. QDs were also observed to
decompose in 1 mM hydrogen peroxide,
releasing free Cd ions (24 ppm). Derfus (2004)
concluded that QD toxicity was relative to
environmental conditions; CdSe QD-induced
toxicity was observed only above concentra-
tions exceeding 0.25 mg/mL and 1 hr of UV
exposure. Adding one or two monolayers of
ZnS to the QDs virtually eliminated cytotoxic-
ity due to oxidation (using the same protocol).
Although ZnS capping material significantly
reduced ambient air oxidation, it did not fully
eliminate photooxidation, with high levels of
free Cd observed in solution after 8 hr under
photooxidative conditions. BSA-coated ZnS-
capped QDs were also found to have reduced
cytotoxicity compared with non-BSA-coated
ZnS-capped QDs at the same concentration
(0.25 mg/mL). Aldana et al. (2001) also
observed photochemical instability in thiol-
coated CdSe QDs, although not at relevant
UV wavelengths (254 nm). It was noted, how-
ever, that the photochemical stability of CdSe
nanocrystals was closely related to the thickness
and packing of the ligand monolayer.
Last, Staphylococcus aureus cultures exposed
to transferrin-conjugated QDs showed marked
increase in ﬂuorescence after 2 weeks of expo-
sure, attributed to intracellular oxidation of the
QDs, with a marked increase in intracellular Se
concentration. Kloepfer et al. (2003) observed
the internalization of both free Cd and Se 
in S. aureus cells but not internalization of
measurable transferrin-conjugated QDs. The
authors also noted that photostability of the
QD conjugates was an issue during prepara-
tion, and QD conjugation procedures were
performed under little or no light to minimize
QD photolysis.
Intracellular and in vivo degradation.
Given that studies indicate QDs may be sus-
ceptible to photolysis and oxidation, the ques-
tion arises as to their in vivo/intracellular
oxidative stability, and a few studies suggest the
possibility of intracellular degradation.
Although Hoshino et al. (2004a) noted that
CdSe/ZnS–SSA QDs could be observed in
EL-4 cells for more than a week, with approxi-
mately 10% of the cells retaining QDs after
10 days in culture, the ﬂuorescent intensity of
cells was observed to gradually decrease and
was highly concentrated in endosomes. QD
fluorescence was possibly diminished by low
pH, oxidation of QD surface structures, or
intracellular factors adsorbed onto QD sur-
faces. Similarly, a substantial loss of QD ﬂuo-
rescence over time was noted by Gao et al.
(2004) and Akerman et al. (2002) upon
administration of QDs to live animals.
Although the exact origin of the loss of QD
ﬂuorescence was not clear, Gao et al. (2004)
stated that recent research in their group sug-
gested that QD surface ligands and coatings
were slowly degraded in vivo, leading to surface
defects and fluorescence quenching. They
noted, however, that QDs coated with a high-
molecular-weight (100 kDa) copolymer and a
grafted 8-carbon alkyl side chain demonstrated
greater in vivo stability than those with simple
polymer and amphiphilic lipid coatings.
Similarly, Chen and Gerion (2004) attributed
the lack of observable genotoxicity of QDs to a
silica coating, which successfully prevented the
interaction of Cd, Se, Zn, and sulfur with pro-
teins and DNA in the nucleus.
Cytotoxicity of QD capping materials.
Relative to in vivo degradation, Hoshino et al.
(2004b) observed that QD surface coatings
such as MUA may be detached under acidic
and oxidative conditions in endosomes and
released into cytoplasm. To assess the toxicity
of surface coatings, Hoshino et al. (2004b)
assayed three QD coating materials (MUA,
cysteamine, and thioglycerol) and two possi-
ble impurities (TOPO and ZnS) for cyto-
toxicity. Treatment of WTK1 cells with
MUA alone for 12 hr resulted in cytotoxicity
at doses > 100 µg/mL. DNA damage was
observed at 50 µg/mL (2 hr of treatment).
Cysteamine was observed to be weakly geno-
toxic when cells were treated for 12 hr. The
toxicity of thioglycerol was negligible.
Hoshino et al. (2004b), observing TPOP to
be cytotoxic and genotoxic, stated that
removal of TPOP from the QD samples is
important in reducing toxicity. Their ﬁndings
provided evidence that QD-induced genotox-
icity was not caused by the QD core but by
hydrophilic QD coatings.
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reviewed here suggest that QD toxicity
depends on multiple factors derived from both
the inherent physicochemical properties of
QDs and environmental conditions. QD size,
charge, concentration, outer coating bioactivity
(capping material and functional groups), and
oxidative, photolytic, and mechanical stability
are each factors that, collectively and individu-
ally, can determine QD toxicity. Of these
physicochemical characteristics, functional
coating and QD core stability figure promi-
nently and likely will be signiﬁcant factors in
assessing the risk of QD toxicity in real-world
exposure scenarios.
Absorption, Distribution,
Metabolism, and Excretion 
of Quantum Dots in Vivo
Several studies have shown QDs may be sys-
temically distributed and may accumulate in
organs and tissues. Absorption, distribution,
metabolism, and excretion (ADME) charac-
teristics are, not surprisingly, highly variable
for QDs because of the wide variation in QD
physicochemical properties. QD size, charge,
concentration, stability, and outer coating
bioactivity each contribute to not only the
potential toxicity of a given QD but also to
their ADME characteristics. Physicochemical
properties in conjunction with environmental
factors and QD stability (oxidative and photo-
lytic lability) together are a paradigm in which
ADME characteristics of QDs can be highly
variable and difﬁcult to predict.
Several in vitro studies have shown QDs to
be incorporated via endocytic mechanisms by
a variety of cell types. Mammalian (HeLa) and
Dictyostelium discoideum (AXS) cells were
observed to incorporate avidin and DHLA-
conjugated CdSe/ZnS QDs via endocytosis
(Jaiswal et al. 2003), and rat primary hepato-
cytes were observed to incorporate
CdSe–MAA QDs (Derfus 2004). Hoshino
et al. (2004a) observed adherence of
CdSe/ZnS–SSA QDs to the surface of EL-4
cells, with subsequent endocytosis and increase
in cytosolic QD concentration in a time-
dependent manner (minutes to hours). Other
studies have shown similar nonspeciﬁc uptake.
Hanaki et al. (2003), exposing Vero cells to
CdSe/ZnS–MUA QDs coated with SSA,
observed endosomal/lysosomal localization of
the QDs near the perinuclear region 5 days
after exposure. Parak et al. (2002) observed
endocytosis and vesicular storage and trans-
port of CdSe/ZnS silicon dioxide–coated QDs
to the perinuclear region in human mammary
tumor cells, and an in vivo study by Dubertret
et al. (2002) demonstrated endocytosis and
active transport of QD micelles (phospholipid
block-copolymer) in Xenopus embryos.
In one instance, QD size was shown to be
a determining factor in subcellular distribution.
Lovric et al. (2005) observed 5.2 nm cationic
CdTe QDs to localize throughout the cyto-
plasm of N9 cells (murine microglial cell line)
but not in the nucleus. In contrast, 2.2-nm
cationic CdTe QDs were observed to localize
in the nuclear compartment within the same
time frame. Hence, in this instance, size, not
charge, was a determining factor in subcellular
localization. It was noted, however, that
because relatively unrestrained passage of
macromolecules up to 9 nm in diameter occurs
through nuclear pores, the size of the QDs (2.2
and 5.2 nm) cannot be the only explanation
for the entry of smaller QDs (2.2 nm) into the
nucleus. Altering the bioactivity of the smaller
2.2 nm CdTe QDs by conjugation to BSA was
seen to limit its localization to the cytosol.
Where nonspeciﬁc endocytic mechanisms
have been shown to be instrumental in QD
uptake by cells, receptor-mediated processes
may also contribute to cellular internalization
when QDs carry bioactive moieties specific
for cell receptor types or surface proteins.
Epidermal growth factor (EGF)–conjugated
CdSe/ZnS QDs proved to be highly speciﬁc
for the EGF receptor (erbB1), demonstrating
rapid internalization into endosomes of
Chinese hamster ovary cells. The endocytic
vesicles were observed to undergo a directed
linear motion mediated by microtubule-
associated motor proteins and vesicular fusion
(Lidke et al. 2004). QDs coated with anti-
Pgp showed good specificity for live HeLa
cells transfected with Pgp-EGFP (EGF pro-
tein), with no apparent nonspeciﬁc cell label-
ing (Jaiswal et al. 2003). Other studies yielded
similar results: CdSe/ZnS QDs conjugated to
peptides speciﬁc for lung, vascular, and lym-
phatic tissues exhibited speciﬁcity for labeling
cell membranes of their targeted tissue types
(Akerman et al. 2002). Dahan et al. (2003)
found that QDs conjugated with glycine
receptor (GlyR1) ligands exhibited speciﬁcity
for endogenous GlyR1 subunits on cultured
spinal neurons. Last, prostate-specific mem-
brane antigen–conjugated QDs specifically
targeted prostate tumors in mice (Gao et al.
2004), and QDs complexed with a viral
(SV40) nuclear localization signal peptide
were observed to readily enter the nuclear
compartment of human HeLa cells (Chen
and Gerion 2004).
In invertebrate cell types, Kloepfer et al.
(2003) observed transferrin-conjugated CdSe
QDs to enter S. aureus bacterial cells, which
do not endocytose but rely on membrane
transporters. The transferrin-conjugated QDs
also showed clear internal labeling in the fungi
Schizosacharomyces pombe and Penicillium
chrysogenum. No internal labeling of nonpath-
ogenic staphylococci and micrococci was
observed, and it was suggested that transferrin-
mediated transport processes were involved in
cell-speciﬁc uptake.
Importantly, where endocytic mechanisms
have been observed in a variety of cell types,
the question of systemic distribution arises.
Although few in vivo studies exist, they suggest
that QDs may be systemically distributed in
rodent animal models and accumulate in a
variety of organs and tissues. EL-4 cells con-
taining CdSe/ZnS–SSA QDs (via endocytosis)
were observed in the kidneys, liver, lung, and
spleen of mice up to 7 days after injection,
with spleen and lung having the most accumu-
lation (fluorescence) (Hoshino et al. 2004a).
Similarly, Ballou et al. (2004), employing QD
coatings of different molecular weights
[MW; methoxy-terminated PEG, MW 750
(mPEG-750), carboxy-terminated PEG, MW
3,400 (COOH–PEG-3400), and ethoxy-ter-
minated PEG, MW 5,000 (mPEG-5000)],
observed differential tissue and organ deposi-
tion in mice in a time- and size (MW)-depen-
dent manner. For instance, mPEG-750 QDs
and COOH–PEG-3400 QDs were cleared
from circulation by 1 hr after injection,
whereas mPEG-5000 QDs remained in circu-
lation for at least 3 hr. At 24 hr after injection,
mPEG-750 QDs were observed in the lymph
nodes, liver, and bone marrow. In contrast, sig-
niﬁcantly less retention of COOH–PEG-3400
and mPEG-5000 QDs was observed in lym-
phatic tissue compared with bone marrow,
liver, and spleen. At 133 days, continued ﬂuo-
rescence of mPEG-750 QDs was observed in
the lymph nodes and bone marrow. A study by
Akerman et al. (2002) yielded comparable
ﬁndings. Lung- and tumor-targeting peptide-
coated CdSe/ZnS QDs injected into mice (iv),
regardless of the peptide used for the coating,
accumulated in both the liver and spleen in
addition to the targeted respiratory tissues.
Interestingly, additionally coating CdSe/ZnS
QDs with PEG (a polymer known to mini-
mize molecular interactions and improve col-
loidal solubilities) nearly eliminated the
nonspeciﬁc uptake of QDs into the liver and
spleen. An in vivo study employing Xenopus
embryos revealed that QDs, once internalized
by cells, subsequently may be transferred to
daughter cells on cell division. Dubertret et al.
(2002), injecting a CdSe/ZnS micelle
(PEG–PE and phosphatidylcholine) conju-
gated with an oligonucleotide into Xenopus
embryos, observed QD labeling of all embry-
onic cell types, including somites, neurons,
axonal tracks, ectoderm, neural crest, and
endoderm. The internalized QDs were local-
ized to both the cytosol and nuclear envelope
and were transferred to daughter cells on cell
division. The progeny of the QD-injected cells
were shown to contain ﬂuorescent QDs after
several days of development.
Metabolic processes and excretory mecha-
nisms involved in the elimination of QDs, 
as well as in vivo bioactivity, remain poorly
understood and have not been well studied.
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In vivo studies suggest that, regardless of the
speciﬁcity of the QD, vertebrate systems tend
to recognize QDs as foreign, with elimination
of the materials through the primary excre-
tory organs/systems: the liver, spleen, and
lymphatic systems. However, this a rough
generalization, and discrepancies in the litera-
ture exist. For instance, subcutaneous injec-
tion of CdSe/ZnS–PEG-coated QDs in mice
showed clearance of the QDs from the site of
injection, with accumulation of QDs in
lymph nodes. In contrast, Akerman et al.
(2002) observed that modification of lung-
and tumor-targeting peptide-conjugated
CdSe/ZnS QDs with a PEG coating nearly
eliminated nonspecific elimination of QDs
via the lymphatic system.
The above studies suggest that QDs may
see variable systemic distribution dependent on
individual QD physicochemical properties.
Although studies are limited, QD tissue/organ
distribution seems to be multifactorial,
depending on QD size, QD core–shell compo-
nents, and the bioactivity of conjugated or
otherwise attached functional groups. Size
alone can markedly affect distribution kinetics,
and QD surface coating can govern serum life-
time and pattern of deposition (Ballou et al.
2004; Lovric et al. 2005). QDs lacking special-
ized functional groups or speciﬁcity have been
shown to be incorporated via endocytic mecha-
nisms by a variety of cell types, both in vivo
and in vitro. In contrast, QDs bearing natural
ligands speciﬁc for cell receptors and cell mem-
brane proteins have been shown to be speciﬁc
for given cell membrane proteins/receptor
types. Several studies have shown nonspeciﬁc
QDs to adhere to cell surfaces, possibly
through interactions of QD with glycoproteins
and glycoplipids in cell membranes. Although
many studies indicate endocytic processes and
intracellular vesicular trafﬁcking and storage of
QDs, the exact mechanisms remain to be elu-
cidated. Subcellular localization is variable, like
systemic distribution, and dependent on QD
physicochemical properties. Such variables,
determined by the unique physicochemical
properties of individual QD types, will prove
signiﬁcant in developing characterization pro-
tocols for QD toxicity screening, given the
nonuniformity in size, QD functional coatings,
core–shell complexes, and outer coating photo-
lytic and oxidative stability.
Correlation of Quantum Dot
Concentrations and Toxicity
Quantum dot dosage/exposure concentrations
reported in the literature vary widely in units of
measurement (e.g., micrograms per milliliter,
molarity, milligrams per kilogram body weight,
QDs per cell), and correlating dosage across
studies is currently challenging. Further, some
QDs were found to be cytotoxic only after
degradation of their core coatings both in vivo
and/or in vitro. Nevertheless, reported values of
dose–response relationships can be assessed in
Table 1. Review articles summary of QD types, exposure concentrations, experimental conditions, and observed toxicity.
Exposure conditions/
QD Model administration QD concentration Exposure duration Toxicity Reference
CdSe/ZnS–SSA EL-4 cells 1 × 106 cells/well 0.1–0.4 mg/mL 0–24 hr Cytotoxic: 0.1 mg/mL altered cell growth; Hoshino et al.
most cells nonviable at 0.4 mg/mL 2004a
CdSe/ZnS–SSA EL-4 cells 200 µL cell 0.1 mg/mL QDs per 2  hr to 7 days No toxicity in mice in vivo Hoshino et al.
suspension injected 5 × 107 cells 2004a
(iv) into mice
CdSe/ZnS WTK1 cells 5 × 104 cells/mL 1–2 µM 12 hr 2 µM QD–COOH induced DNA damage Hoshino et al.
conjugates: NH2, at 2 hr 2004b
OH, OH/COOH, DNA repair on prolonged incubation
H2/OH, MUA, COOH (12 hr)
CdSe/ZnS–MUA Vero, HeLa, and 100 µL QDs/3 × 104 0–0.4 mg/mL 24 hr Cytotoxic: 0.2 mg/mL, Vero; Shiohara et al.
primary human cells 0.1 mg/mL, HeLa; 2004
hepatocytes 0.1 mg/mL, hepatocytes;
CdTe Rat 1 × 105 cells/cm2 0.01–100 µg/mL 2–24 hr 10 µg/mL cytotoxic Lovric et al.
pheochromocytoma 2005
cells, murine
microglial cells
CdSe–MAA, Primary rat 62.5–1,000 µg/mL 1–8 hr Cytotoxic: 62.5 µg/mL cytotoxic under Derfus 2004
TOPO QDs hepatocytes oxidative/photolytic conditions
No toxicity on addition of ZnS cap
QD micelles: Xenopus 5 × 109 QDs/cell 1.5–3 nL of 2.3 µM QDs Days 5 × 109 QDs/cell: cell abnormalities, Dubertret et al.
CdSe/ZnS QDs in blastomeres (~ 0.23 pmol/cell) injected, ~ 2.1 × 109 to altered viability and motility 2002
(PEG–PE) and 4.2 × 109 injected No toxicity at 2 × 109 QDs/cell
phosphatydilcholine QDs/cell
CdSe/ZnS Mice 200-µL tail vein Injections; ~ 180 nM QD, 15 min cell No signs of localized necrosis at the Ballou et al.
amp-QDs, and injection ~ 20 pmol QD/g animal incubations, sites of deposition 2004
mPEG QDs weight 1–133 days 
in vivo
CdSe/ZnS–DHLA Dictyostelium 400–600 nM 45–60 min No effects on cell growth Jaiswal et al.
discoideum and 2003
HeLa cells
Avidin-conjugated HeLa cells 0.5–1.0 µM 15 min No effect on cell growth, development Jaiswal et al.
CdSe/ZnS QDs 2003
CdSe/ZnS– Mice Tail vein injection 60 µM QD/g animal weight, Not given Mice showed no noticeable ill effects Larson et al.
amphiphilic micelle 1 µM and 20 nM ﬁnal QD after imaging 2003
concentration
CdSe/ZnS–DHLA  Mice, B16F10 cells 5 ×104B16F10 cells 100 µL of B16F10 cells used 4–6 hr cell No toxicity observed in cells or mice Voura et al.
QDs with 10 µL QDs for tail vein injection, incubation, mice 2004
(~ 10 pmol), tail vein ~ 2 × 105 to 4 × 105 cells sacriﬁced at 
(iv) injection injected 1–6 hr
CdSe/ZnS–MUA QDs; Vero cells 0.4 mg/mL  0.24 mg/mL 2 hr 0.4 mg/mL MUA/SSA–QD complexes Hanaki et al.
QD–SSA complexes did not affect viability of Vero cells 2003
CdSe/ZnS HeLa cells 1 × 106 cells 10 pmol QDs/1 × 105 cells 10 days (cell 10 nM QD had minimal impact on cell Chen and Gerion
(~ 10 nM) culture) survival 2004Toxicologic review of quantum dots
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Table 1. Of note, those studies that observed
no cytotoxicity generally employed protocols
that used short-term acute exposures, where
cells were in contact with QDs for 15 min to
8 hr (e.g., Hanaki et al. 2003; Jaiswal et al.
2003; Voura et al. 2004). For instance, studies
by Jaiswal et al. (2003), in which no cytotoxic-
ity was observed, employed acute exposures of
cells to QDs for 15 min to 2 hr, after which
time cells where washed and observations
made. Similar exposure times (2 hr) were
employed by Hanaki et al. (2003). In contrast,
QD-induced cytotoxicity was generally found
in those studies that tended to be longer in
nature, with exposure times from 2 hr to sev-
eral days. For example, Hoshino et al. (2004a),
Shiohara et al. (2004), and Lovric et al. (2005)
employed 24-hr exposures.
Discussion
Cadmium and selenium, two of the most
widely used constituent metals in QD core
metalloid complexes, are known to cause acute
and chronic toxicities in vertebrates and are of
considerable human health and environmental
concern (Fan et al. 2002; Hamilton 2004;
Henson and Chedrese 2004; Kondoh et al.
2002; Poliandri et al. 2003; Satarug and
Moore 2004; Spallholz and Hoffman 2002).
For instance, Cd, a probable carcinogen, has a
biologic half-life of 15–20 years in humans,
bioaccumulates, can cross the blood–brain bar-
rier and placenta, and is systemically distrib-
uted to all bodily tissues, with liver and kidney
being target organs of toxicity. The potential
environmental impacts of Se contamination
are well understood from Kesterson Reservoir,
California, and Belews Lake, North Carolina,
where a marked impact on the local ecosystem
resulted from elevated environmental concen-
trations of Se. Because of QD metalloid core
composition, the uniqueness of each type of
QD, the oxidative and photochemical lability
of certain types of QDs, and the dearth of
information on routes of exposure and the
environmental transport and fate of QD mate-
rials, the potential risks posed by QD materials
to human health and the environment should
be seriously considered.
The likely increase in prevalence of QD
products in society, in tandem with their
potential toxicity, necessitates elucidation of
the potential adverse effects of these materials,
not only for the protection of human health
and environmental integrity but also to aid
industry and regulatory bodies in maximizing
the use of these materials. Given the potential
societal benefits offered by QD technology,
elucidating the mechanisms and sources of QD
toxicity will help avoid the pitfalls encountered
by the misapplication of previous technologies.
Nanotoxicologic information, currently lack-
ing, will be vital to this process, in aiding
industry in producing QDs of minimal risk,
and in elucidating the mechanisms of action of
QDs, as well as their environmental transport
and fate. Only with this knowledge can the
biocompatibility of QD technology with the
social and ecologic systems in which these
materials will be applied be achieved, and can
we ensure that this technology develops
responsibly, with sound public support.
Summary
The studies reviewed here suggest several key
points, in particular, that not all QDs are alike
and that engineered QDs cannot be considered
a uniform group of nanomaterials. QD ADME
and toxicity depend on multiple factors derived
from both inherent physicochemical properties
and environmental conditions; QD size,
charge, concentration, outer coating bioactivity
(capping material and functional groups), and
oxidative, photolytic, and mechanical stability
have each been implicated as determining fac-
tors in QD toxicity. Hence, it is likely that
grouping or classification of QDs as to their
potential toxicities based on size or other
physicochemical properties alone will, early on,
prove troublesome, and each QD type will
need to be characterized individually as to its
potential toxicity. In summary, the ﬁndings in
these reviews suggest that under certain condi-
tions QDs may pose environmental and human
health risks as determined by rodent animal
models and in vitro cell cultures.
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